Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 3 years, the average EBITDA Per Share Growth Rate was -32.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Aspen Aerogels was 34.00% per year. The lowest was -119.70% per year. And the median was -6.40% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Aspen Aerogels 3-Year EBITDA Growth Rate Related Terms
ASPN vs AIRJ, PPIH, JLHL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Aspen Aerogels's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Aerogels 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Aspen Aerogels's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Aspen Aerogels's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -32.30% mean?
Aspen Aerogels (ASPN) has a 3-Year EBITDA Growth Rate of -32.30% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Aspen Aerogels and its competitors. According to the industry distribution chart, Aspen Aerogels ranks #1274 out of 1407 companies in the Chemicals industry, placing it in the top 90.5%.
Is Aspen Aerogels' 3-Year EBITDA Growth Rate too high?
Aspen Aerogels' current 3-Year EBITDA Growth Rate is -32.30%. Based on the distribution chart, Aspen Aerogels ranks #1274 out of 1407 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Aspen Aerogels has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aspen Aerogels' 3-Year EBITDA Growth Rate compare to AIRJ and PPIH?
According to the Chemicals industry distribution chart, Aspen Aerogels ranks #1274 out of 1407 companies for 3-Year EBITDA Growth Rate. This places Aspen Aerogels in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.90, based on 1,407 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Aspen Aerogels and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspen Aerogels's current 3-Year EBITDA Growth Rate is -32.30%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Aerogels stock overvalued right now?
Based on GuruFocus' analysis, Aspen Aerogels (ASPN) is currently considered Fairly Valued. The stock's GF Value™ is $5.01, compared to a current price of $7.31 — trading 45.9% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -32.30%. Aspen Aerogels' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Aspen Aerogels (ASPN), the current 3-Year EBITDA Growth Rate is -32.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspen Aerogels (ASPN) Overvalued in 2026?
Based on GuruFocus' analysis, Aspen Aerogels stock appears to be overvalued.
The current stock price of $7.31 is trading 45.9% above its estimated GF Value™ of $5.01.
GuruFocus considers Aspen Aerogels to be Fairly Valued.
Key valuation signals for ASPN:
3-Year EBITDA Growth Rate: -32.30%
GF Value™: $5.01 vs. price of $7.31 (45.9% above fair value)
No single metric tells the full story. See the ASPN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
68GF Score
Get the complete analysis for ASPN
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASPN has been successfully added to your 
